NCT05387863NARecruiting

Decision Aid (DA) for Renal Patients

NYU Langone Health

Start Date

9/12/2022

Completion Date

9/1/2026

Summary

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter. * Patients scheduled for standard-of-care clinical exams with the NYU Urology Department Exclusion Criteria: * Stage IV cancer of any type * Inability to provide informed consent * Vulnerable subjects will not be recruited

Interventions

OTHER

Decision Aid (DA) Web Tool

OTHER

Institutional Pamphlet

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Kidney TumorRenal Cancer

Locations

NYU Langone Health

New York, New York 10016

United States